Literature DB >> 9655357

Renal tubular function in beta-thalassemia.

A Sumboonnanonda1, P Malasit, V S Tanphaichitr, S Ong-ajyooth, S Sunthornchart, S Pattanakitsakul, S Petrarat, A Assateerawatt, A Vongjirad.   

Abstract

Studies of the renal involvement in thalassemic syndromes have been varied and few. This study was designed to define the renal abnormalities associated with beta-thalassemia and to correlate the renal findings with clinical parameters. One hundred and four beta-thalassemic children with various disease severity were studied. The patients were divided into three groups: 48 with severe anemia [hematocrit (Hct) < 25%], 31 on a hypertransfusion program and desferrioxamine treatment, and 25 with moderate anemia (Hct > 25%). The results were compared with 15 normal children. Significantly higher levels of proteinuria and low molecular weight proteinuria were found in all patients compared with normal children. Aminoaciduria was detected in one-third of patients. Thalassemic patients had significantly lower morning urine osmolarity, higher urine N-acetyl-beta-D-glucoseminidase and malondialdehyde (MDA, an indicator of lipid peroxidation). Patients with severe anemia had significantly higher low-molecular weight proteinuria and MDA, and lower urine osmolarity than those with moderate anemia. Our data confirmed the high frequency of renal abnormalities in beta-thalassemia patients and indicated some degree of proximal tubular dysfunction. Severity of the abnormalities correlated with the degree of anemia and were least severe in patients on hypertransfusion and desferrioxamine therapy. This suggested that the damage might be caused by anemia and increased oxidation induced by excess iron deposits.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655357     DOI: 10.1007/s004670050453

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Nocturnal enuresis in sickle cell disease and thalassemia major: associated factors in a clinical sample.

Authors:  Ozalp Ekinci; Tanju Celik; Şule Ünal; Gonul Oktay; Fevziye Toros; Cahit Ozer
Journal:  Int J Hematol       Date:  2013-09-08       Impact factor: 2.490

Review 2.  Renal complications of beta-thalassemia major in children.

Authors:  Ashraf Bakr; Youssef Al-Tonbary; Ghada Osman; Rasha El-Ashry
Journal:  Am J Blood Res       Date:  2014-09-05

3.  GFR in Patients with β-Thalassemia Major.

Authors:  Gai Milo; Revital Feige Gross Nevo; Idit Pazgal; Anat Gafter-Gvili; Ofer Shpilberg; Uzi Gafter; Arie Erman; Pinhas Stark
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-11       Impact factor: 8.237

4.  Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.

Authors:  Waad-Allah S Mula-Abed; Huda S Al-Hashmi; Muhanna N Al-Muslahi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

5.  Renal tubular dysfunction in alpha-thalassemia.

Authors:  Achra Sumboonnanonda; Prida Malasit; Voravarn S Tanphaichitr; Sompong Ong-ajyooth; Siripan Petrarat; Arun Vongjirad
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

6.  Early markers of renal dysfunction in patients with beta-thalassemia major.

Authors:  Masoumeh Mohkam; Bibi Shahin Shamsian; Atoosa Gharib; Shahin Nariman; Mohammad T Arzanian
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

7.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

8.  Renal function in children with beta-thalassemia major and thalassemia intermedia.

Authors:  Vladislav Smolkin; Raphael Halevy; Carina Levin; Miguel Mines; Waheeb Sakran; Katzap Ilia; Ariel Koren
Journal:  Pediatr Nephrol       Date:  2008-06-25       Impact factor: 3.714

9.  Renal tubule function in beta-thalassemia after hematopoietic stem cell transplantation.

Authors:  Achra Sumboonnanonda; Kleebsabai Sanpakit; Nuntawan Piyaphanee
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

10.  Intraperitoneal tenoxicam to prevent abdominal adhesion formation in a rat peritonitis model.

Authors:  Fikret Ezberci; Ertan Bulbuloglu; Pinar Ciragil; Mustafa Gul; Ergul Belge Kurutas; Serdar Bozkurt; I Taner Kale
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.